Mitofusin 2 (MFN2) Peptide
MFN2
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all MFN2 products
- MFN2 (Mitofusin 2 (MFN2))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- LEQEIAAMNK KIEVLDSLQS KAKLLRNKAG WLDSELNMFT HQYLQPSR
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of MFN2 antibody,
Alternative Names: Mitofusin 2 control peptide, Mitofusin 2 antibody Blocking Peptide, Anti-Mitofusin 2 Blocking Peptide, CMT2A Blocking Peptide, CMT2A2 Blocking Peptide, CPRP1 Blocking Peptide, HSG Blocking Peptide, KIAA0214 Blocking Peptide, MARF Blocking Peptide, MFN2 Blocking Peptide, Mitofusin 2, Mitofusin -2, Mitofusin 2, Mitofusin -2 Blocking Peptide, Mitofusin 2 Blocking Peptide - Purification
- The antibody is affinity purified from rabbit antiserum by affinity chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide is removed by chromatogramphy using non-phosphopeptide corresponding to the phosphorylation site.
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- MFN2 (Mitofusin 2 (MFN2))
- Background
- MFN2 is a mitochondrial membrane protein that participates in mitochondrial fusion and contributes to the maintenance and operation of the mitochondrial network. It is involved in the regulation of vascular smooth muscle cell proliferation, and it may play a role in the pathophysiology of obesity. Mutations in this gene cause Charcot-Marie-Tooth disease type 2A2, and hereditary motor and sensory neuropathy VI, which are both disorders of the peripheral nervous system. Defects in this gene have also been associated with early-onset stroke.
- Molecular Weight
- 86 kDa
-
You are here:
